FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited.

FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited.

Item
http://www.wikidata.org/entity/Q38874036
Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers.Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes.Targeted attack: mechanisms by which ovarian cancers suppress the immune system.Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro.Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study.Cellular Senescence in the Treatment of Ovarian Cancer.Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals
P2860

FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited.

Item
http://www.wikidata.org/entity/Q38874036
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited.
@en
type
label
FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited.
@en
prefLabel
FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited.
@en
P2093
P304
P31
P356
10.1016/J.YGYNO.2016.06.013
P407
P433
P478
P577
P698
P921